Sigma Emerging Markets Ltd. - Net Worth and Insider Trading
Sigma Emerging Markets Ltd. Net Worth
The estimated net worth of Sigma Emerging Markets Ltd. is at least $78,904 dollars as of 2024-09-21. Sigma Emerging Markets Ltd. is the 10% Owner of Aileron Therapeutics Inc and owns about 21,154 shares of Aileron Therapeutics Inc (ALRN) stock worth over $78,904. Details can be seen in Sigma Emerging Markets Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sigma Emerging Markets Ltd. has not made any transactions after 2017-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sigma Emerging Markets Ltd.
Sigma Emerging Markets Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sigma Emerging Markets Ltd. owns 1 companies in total, including Aileron Therapeutics Inc (ALRN) .
Click here to see the complete history of Sigma Emerging Markets Ltd.’s form 4 insider trades.
Insider Ownership Summary of Sigma Emerging Markets Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 10 percent owner |
Sigma Emerging Markets Ltd. Latest Holdings Summary
Sigma Emerging Markets Ltd. currently owns a total of 1 stock. Sigma Emerging Markets Ltd. owns 21,154 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $78,904.
Latest Holdings of Sigma Emerging Markets Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 21,154 | 3.73 | 78,904 |
Holding Weightings of Sigma Emerging Markets Ltd.
Sigma Emerging Markets Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Sigma Emerging Markets Ltd. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 9,500 shares on July 5, 2017, which cost Sigma Emerging Markets Ltd. around $3 Million.
Insider Trading History of Sigma Emerging Markets Ltd.
- 1
Sigma Emerging Markets Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Sigma Emerging Markets Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sigma Emerging Markets Ltd. is 18.28%. GuruFocus also compares Sigma Emerging Markets Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Sigma Emerging Markets Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sigma Emerging Markets Ltd.'s insider trading performs compared to the benchmark.
Performance of Sigma Emerging Markets Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.38 | | | | | |
| Relative Return to S&P 500(%) | -3.2 | | | | | |
Sigma Emerging Markets Ltd. Ownership Network
Sigma Emerging Markets Ltd. Owned Company Details
What does Aileron Therapeutics Inc do?
Who are the key executives at Aileron Therapeutics Inc?
Sigma Emerging Markets Ltd. is the 10 percent owner of Aileron Therapeutics Inc. Other key executives at Aileron Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and 10 percent owner Muneer A Satter .
Aileron Therapeutics Inc (ALRN) Insider Trades Summary
Over the past 18 months, Sigma Emerging Markets Ltd. made no insider transaction in Aileron Therapeutics Inc (ALRN). Other recent insider transactions involving Aileron Therapeutics Inc (ALRN) include a net sale of 95,059 shares made by , and a net purchase of 5,301 shares made by James Brian Windsor .
In summary, during the past 3 months, insiders sold 0 shares of Aileron Therapeutics Inc (ALRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 95,059 shares of Aileron Therapeutics Inc (ALRN) were sold and 5,301 shares were bought by its insiders, resulting in a net sale of 89,758 shares.
Aileron Therapeutics Inc (ALRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aileron Therapeutics Inc Insider Transactions
Sigma Emerging Markets Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Sigma Emerging Markets Ltd.. You might contact Sigma Emerging Markets Ltd. via mailing address: Omc Chambers, Wickhams Cay 1, Road Town, Tortola D8 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
